![Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration | Eye Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration | Eye](https://media.springernature.com/w136h75/springer-static/image/art%3A10.1038%2Fs41433-022-02222-z/MediaObjects/41433_2022_2222_Fig1_HTML.png)
Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration | Eye
![PDF) Intravitreale Triamcinolon-Injektion: Vergleich zwischen Patienten mit Astvenenthrombose, Zentralvenenthrombose und diabetischem Makulaödem PDF) Intravitreale Triamcinolon-Injektion: Vergleich zwischen Patienten mit Astvenenthrombose, Zentralvenenthrombose und diabetischem Makulaödem](https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg)
PDF) Intravitreale Triamcinolon-Injektion: Vergleich zwischen Patienten mit Astvenenthrombose, Zentralvenenthrombose und diabetischem Makulaödem
![Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration | Eye Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration | Eye](https://media.springernature.com/w136h75/springer-static/image/art%3A10.1038%2Fs41433-020-01383-z/MediaObjects/41433_2020_1383_Fig1_HTML.png)
Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration | Eye
![Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration | Eye Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration | Eye](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Feye.2008.267/MediaObjects/41433_2009_Article_BFeye2008267_Fig1_HTML.gif)